Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions globally, posing significant challenges to healthcare systems and societies. Despite advances in early biomarkers, current diagnostic tools often fail to capture the diversity of neurophysiological subtypes and the individualized nature of disease progression. Virtual brain twins have the capacity to integrate heterogeneous data and capture the inter-individual variability, but their application in the case of AD is challenging due to non-identifiability of relevant parameters from spontaneous brain activity.
The PINGED project aims to address this gap by developing a personalized virtual brain modeling framework that integrates multimodal neuroimaging data. Specifically, it combines resting-state functional MRI (fMRI) with EEG responses to noninvasive brain stimulation techniques such as temporal interference (TI) and transcranial magnetic stimulation (TMS). The perturbational approach improves the estimation of mechanistic parameters that reflect an individual’s position along the AD progression trajectory by utilizing the information contained in the brain response as compared to spontaneous activity.
By focusing on individual variability and mechanistic modeling, PINGED contributes to the broader goals of personalized medicine and precision diagnostics. The project’s outcomes are expected to support earlier and more accurate stratification of patients, inform clinical decision-making, and ultimately improve therapeutic outcomes. In doing so, PINGED aligns with strategic EU priorities in health innovation and digital transformation.